Search Results for "Genital Squamous Cell Carinoma"

03:13 EST 27th November 2015 | BioPortfolio

Matching Channels

Squamous Cell Carcinoma

Squamous cell carcinoma (SCC) is a carcinomatous cancer occurring in many different organs, including the skin, lips, mouth, esophagus, urinary bladder, prostate, lungs, vagina, and cervix. It is a ...

CIN and squamous cell carcinoma stage IA1

Oral Squamous Cell Carcinoma

Squamous cell cancer of the anus and vulva


Matching News

Patients with Multiple Squamous Cell Carcinomas Should be Frequently Monitored

Patients with multiple sites of cutaneous squamous cell carcinoma (a type of skin cancer) have a significantly increased risk of developing a recurrence or spread to their lymph nodes, warranting freq...

Skin squamous cell carcinoma

Researchers have uncovered new genetic alterations involved in the development of skin squamous cell carcinoma.

Can We Do Better with a New Chemotherapy for Squamous Cell NSCLC?

_kmq.push(["trackClickOnOutboundLink","wpa2a_8","Article link clicked",{"Title":"","Page":"Can We Do Better with a New Chemotherapy for Squamous Cell NSCLC?"}]);   A Japanese study of squamous ce...

Squamous cell carcinoma can develop on verrucous lesions

(HealthDay)—Squamous cell carcinoma (SCC) can develop on long-standing verrucous lesions, according to a report published as a letter to the editor in the October issue of The Journal of Dermatology...

EC approves nivolumab for patients with previously-treated advanced squamous non-small cell lung cancer

The EC has approved nivolumab for the treatment of locally advanced or metastatic squamous non-small cell lung cancer after prior chemotherapy... The post EC approves nivolumab for patients with previ...

Opdivo® Receives Expanded Approval for an Additional Type of Lung Cancer

The United States Food and Drug Administration (FDA) has expanded the approval of Opdivo® (nivolumab) for the treatment of non-squamous, non-small cell lung cancer. Non-small cell lung cancer (NSCLC)...

FDA approves Opdivo in RCC

FDA approved Opdivo nivolumab from Bristol-Myers Squibb Co. (NYSE:BMY) to treat advanced renal cell carcinoma in patients who have received prior anti-angiogenic therapy. The approval came well in adv...

FDA Approves Portrazza (necitumumab) for Advanced Squamous Non-Small Cell Lung Cancer

November 24, 2015 -- The U.S. Food and Drug Administration today approved Portrazza (necitumumab) in combination with two forms of chemotherapy to treat patients with advanced (metastatic) squamous no...

Matching PubMed Articles

Invasive Squamous Cell Carcinoma with Osteomyelitis of the Foot A Case Report.

Squamous cell carcinomas are often seen on the sun-exposed areas of the skin and are rarely observed on the digits of the foot. However, there have been incidences of squamous cell carcinoma developin...

Methylation of RASSF1A gene promoter and the correlation with DNMT1 expression that may contribute to esophageal squamous cell carcinoma.

Esophageal squamous cell carcinoma is one of the most common malignancies in the world. Studies have confirmed that there are many genes abnormally hypermethylated in esophageal squamous cell carcinom...

Expression and clinical significance of ADAM17 protein in esophageal squamous cell carcinoma.

We examined disintegrin and metalloproteinase 17 (ADAM17) protein expression in esophageal squamous cell carcinoma and its clinical and pathological correlated factors. Western blotting and immunohist...

Molecular characterization of oral squamous cell carcinoma using targeted next generation sequencing.

Many genetic factors play an important role in the development of oral squamous cell carcinoma. The aim of this study was to assess the mutational profile in oral squamous cell carcinoma using formali...

Squamous cell carcinoma of the lip survival rate.

Squamous Cell Carcinoma (SCC) of the lip represents about 20% of all oral carcinomas. It is more common in men, peaking during their sixth and seventh decade, and is more prevalent in the lower lip.

Search Whole site using Google


Advertisement Advertisement